A Pricentric Brief by Sean Skulski Background of the GCC-DR As the price for pharmaceuticals continued to rise, the Gulf countries sought to harmonize efforts to control costs. Formed in May 1999, the Gulf Central Committee for Drug Registration (GCC-DR) aimed to provide Gulf countries with safe and effective medicines at reasonable, more affordable prices. [...]The post The Effect of Reference Pricing in the Gulf Central Committee Countries appeared first on Alliance Life Sciences.